Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Proneuron Biotechnologies (Israel) Limited

Proneuron Biotechnologies is developing therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. The technology derives from research on key mechanisms in the dialogue between the nervous and immune systems originating from The Weizmann Institute of Science. Proneuron's novel strategy is to modulate these systems to treat disorders hitherto considered untreatable. Using this natural approach, induction of central nervous system (CNS) regeneration was achieved in animal models. Proneuron's proprietary process for training human cells is being used in Phase I clinical trials of Autologous Macrophage therapy for acute spinal cord injury.Another revolutionary development takes advantage of another immune activity in the CNS. The T-cell and immunization therapies under development were shown to protect against secondary neural degeneration in preclinical animal models, and are seen as pioneering tools in neurotherapeutics.

Also under development is Immune Privilege Factor (IPF), a small immunosuppressive peptide normally associated with the CNS which has great potential for treating several neurological and ophthalmologic inflammatory conditions.

Proneuron operates state-of-the-art facilities in the Kiryat Weizmann Science Park, Ness-Ziona, Israel, and collaborates with scientists and physicians at renowned medical centers in Israel and abroad.


Contact Details:
P.O.Box 277
Ness-Ziona
74101
Israel
Tel:+972 8 9409550
Fax:+972 8 9409560
Email:info@proneuron.com
WWW:

www.biotechltd.com/




Proneuron Biotechnologies (Israel) Limited (PRW) Financial information Links from Barchart

PRW Quote from from Barchart.com
PRW Chart from from Barchart.com
PRW Profile from from Barchart.com
PRW Opinion from from Barchart.com

View more Proneuron Biotechnologies (Israel) Limited finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 334 times since April 2007, the link to the organisation's website has been followed 81 times

Recent Search Terms used to find this page: Proneuron Biotechnologies 972 | Proneuron Israel | proneuron biotechnologies | Proneuron Biotechnologies Macrophage 2009 | Proneuron Biotechnologies Israel Ltd | proneuron biotechnologies glaucoma | Proneuron | proneuron biotechnologies | proneuron biotechnologies | .

Search for more companies in Ness-Ziona

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Proneuron Biotechnologies (Israel) Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.